Outcome Scores in Pediatric Rheumatology

Gabriella Giancane; Silvia Rosina; Alessandro Consolaro; Nicolino Ruperto

doi:10.1007/s11926-021-00988-x

Outcome Scores in Pediatric Rheumatology

Gabriella Giancane, Silvia Rosina, Alessandro Consolaro, Nicolino Ruperto

Research output: Contribution to journal › Review article › peer-review

Abstract

PURPOSE OF REVIEW: Providing a summary of the latest research on outcome measures in juvenile idiopathic arthritis, childhood -onset systemic lupus erythematosus, and juvenile dermatomyositis.

RECENT FINDINGS: A rational management of patients with pediatric rheumatic diseases requires the regular assessment of the level of disease activity and damage, as well as the evaluation of therapeutic response through validated and standardized outcome measures. Ideally, such tools should be simple, feasible, and easily applicable in routine care. Recently, there has been a great deal of effort to refine existing tools and devise novel outcome measures, aiming to address the various aspects of disease impact and to improve the reliability of research studies and clinical trials. The newest outcome tools in pediatric rheumatology have markedly enlarged the spectrum of health domains assessable in a standardized way, thus increasing the reliability of evaluation of clinical response and fostering future clinical trials.

Original language	English
Pages (from-to)	23
Journal	Current Rheumatology Reports
Volume	23
Issue number	4
DOIs	https://doi.org/10.1007/s11926-021-00988-x
Publication status	Published - Mar 8 2021

Keywords

Arthritis, Juvenile/drug therapy
Child
Humans
Lupus Erythematosus, Systemic/therapy
Outcome Assessment, Health Care
Reproducibility of Results
Rheumatology

Access to Document

10.1007/s11926-021-00988-x

Cite this

@article{77365bd3466f43f88e1c2dbec0d713b2,

title = "Outcome Scores in Pediatric Rheumatology",

abstract = "PURPOSE OF REVIEW: Providing a summary of the latest research on outcome measures in juvenile idiopathic arthritis, childhood -onset systemic lupus erythematosus, and juvenile dermatomyositis.RECENT FINDINGS: A rational management of patients with pediatric rheumatic diseases requires the regular assessment of the level of disease activity and damage, as well as the evaluation of therapeutic response through validated and standardized outcome measures. Ideally, such tools should be simple, feasible, and easily applicable in routine care. Recently, there has been a great deal of effort to refine existing tools and devise novel outcome measures, aiming to address the various aspects of disease impact and to improve the reliability of research studies and clinical trials. The newest outcome tools in pediatric rheumatology have markedly enlarged the spectrum of health domains assessable in a standardized way, thus increasing the reliability of evaluation of clinical response and fostering future clinical trials.",

keywords = "Arthritis, Juvenile/drug therapy, Child, Humans, Lupus Erythematosus, Systemic/therapy, Outcome Assessment, Health Care, Reproducibility of Results, Rheumatology",

author = "Gabriella Giancane and Silvia Rosina and Alessandro Consolaro and Nicolino Ruperto",

year = "2021",

month = mar,

day = "8",

doi = "10.1007/s11926-021-00988-x",

language = "English",

volume = "23",

pages = "23",

journal = "Current Rheumatology Reports",

issn = "1523-3774",

publisher = "Current Science, Inc.",

number = "4",

}

TY - JOUR

T1 - Outcome Scores in Pediatric Rheumatology

AU - Giancane, Gabriella

AU - Rosina, Silvia

AU - Consolaro, Alessandro

AU - Ruperto, Nicolino

PY - 2021/3/8

Y1 - 2021/3/8

N2 - PURPOSE OF REVIEW: Providing a summary of the latest research on outcome measures in juvenile idiopathic arthritis, childhood -onset systemic lupus erythematosus, and juvenile dermatomyositis.RECENT FINDINGS: A rational management of patients with pediatric rheumatic diseases requires the regular assessment of the level of disease activity and damage, as well as the evaluation of therapeutic response through validated and standardized outcome measures. Ideally, such tools should be simple, feasible, and easily applicable in routine care. Recently, there has been a great deal of effort to refine existing tools and devise novel outcome measures, aiming to address the various aspects of disease impact and to improve the reliability of research studies and clinical trials. The newest outcome tools in pediatric rheumatology have markedly enlarged the spectrum of health domains assessable in a standardized way, thus increasing the reliability of evaluation of clinical response and fostering future clinical trials.

AB - PURPOSE OF REVIEW: Providing a summary of the latest research on outcome measures in juvenile idiopathic arthritis, childhood -onset systemic lupus erythematosus, and juvenile dermatomyositis.RECENT FINDINGS: A rational management of patients with pediatric rheumatic diseases requires the regular assessment of the level of disease activity and damage, as well as the evaluation of therapeutic response through validated and standardized outcome measures. Ideally, such tools should be simple, feasible, and easily applicable in routine care. Recently, there has been a great deal of effort to refine existing tools and devise novel outcome measures, aiming to address the various aspects of disease impact and to improve the reliability of research studies and clinical trials. The newest outcome tools in pediatric rheumatology have markedly enlarged the spectrum of health domains assessable in a standardized way, thus increasing the reliability of evaluation of clinical response and fostering future clinical trials.

KW - Arthritis, Juvenile/drug therapy

KW - Child

KW - Humans

KW - Lupus Erythematosus, Systemic/therapy

KW - Outcome Assessment, Health Care

KW - Reproducibility of Results

KW - Rheumatology

U2 - 10.1007/s11926-021-00988-x

DO - 10.1007/s11926-021-00988-x

M3 - Review article

C2 - 33683471

SN - 1523-3774

VL - 23

SP - 23

JO - Current Rheumatology Reports

JF - Current Rheumatology Reports

IS - 4

ER -

Outcome Scores in Pediatric Rheumatology

Abstract

Keywords

Access to Document

Fingerprint

Cite this